How Can Dynamic Facial Expression Lines Be Effectively Addressed In Combination With Ablative Laser Skin Resurfacing Equipment? Unlock The Power

Dynamic facial expression lines are best managed by treating both the skin and the underlying muscle activity. Ablative laser resurfacing improves photoaged skin, texture, and established etched-in lines, but it does not stop the muscle contractions that repeatedly fold the skin. For forehead lines, glabellar lines, and crow’s feet, botulinum toxin type A is generally used as an adjunct 1–2 weeks before ablative resurfacing.

Ablative resurfacing treats the skin’s surface and stimulates remodeling; botulinum toxin temporarily reduces the muscle movements that recreate expression lines. Combining the two can protect the resurfaced skin during early collagen formation and produce a more durable improvement.

Why Ablative Resurfacing Alone May Be Insufficient

Dynamic lines are driven by muscle movement

Dynamic lines appear or deepen when facial muscles contract. Common examples include horizontal forehead creases, vertical glabellar lines, and lateral canthal lines, often called crow’s feet.

Ablative lasers remove controlled layers of damaged skin and trigger wound healing, collagen synthesis, and tissue remodeling. However, they do not eliminate the muscle contractions responsible for repeatedly folding the skin.

Repeated folding can limit the result

After resurfacing, ongoing expression-related movement can continue to crease newly treated skin. This may cause dynamic lines to recur or reduce the longevity of the resurfacing result.

The key principle is to reduce mechanical folding while the skin is healing and remodeling—not simply to remove more surface tissue.

How to Combine Botulinum Toxin With Ablative Resurfacing

Use botulinum toxin before the laser procedure

An adjunctive injection of botulinum toxin type A approximately 1–2 weeks before ablative resurfacing allows time for its muscle-relaxing effect to develop before the laser treatment.

This sequence addresses the two contributing factors separately: the toxin reduces muscle-driven folding, while the laser treats surface damage and stimulates new collagen formation.

Target the relevant expression muscles

Treatment should be directed toward the muscle groups responsible for the patient’s specific lines. These may include the muscles contributing to forehead movement, glabellar contraction, or lateral eye-area expression lines.

Injection patterns and dosing must be individualized by a qualified medical professional because excessive weakening or inaccurate placement can produce unwanted asymmetry or functional effects.

Protect the remodeling phase

Botulinum toxin commonly provides muscle immobilization for approximately 3–4 months, which overlaps with the critical early period of collagen synthesis and tissue remodeling after resurfacing.

Reducing movement during this interval helps limit repetitive creasing while the treated skin is developing its longer-term result.

What Each Treatment Contributes

The ablative laser improves skin quality

Ablative resurfacing is primarily directed at the skin itself. Depending on the device and treatment plan, it can improve photodamage, uneven texture, and static lines that remain visible even when the face is relaxed.

It is therefore most valuable for the surface and structural component of facial aging.

Botulinum toxin reduces the mechanical cause

Botulinum toxin type A temporarily reduces contraction of selected facial muscles. This is particularly relevant when lines are strongly associated with facial expression and become less prominent when the muscles are relaxed.

It is therefore most valuable for the movement-related component of facial aging.

The combination is complementary

Neither treatment fully substitutes for the other. Laser resurfacing cannot reliably prevent muscle-driven recurrence, while botulinum toxin does not resurface damaged skin or correct all static lines.

Combining them creates a more complete treatment strategy: reduce the folding force and improve the skin that has already been affected.

Planning the Procedure Safely

Assess dynamic and static components first

The clinician should determine whether the lines are primarily dynamic, static, or a mixture of both. Dynamic lines appear with movement, while static lines remain visible at rest.

The stronger the static component, the more important it is to set realistic expectations: muscle relaxation may reduce further folding, but resurfacing may be needed to improve the established etched line.

Coordinate the treatment schedule

A practical sequence is:

Evaluate the expression lines and relevant muscle activity.
Administer botulinum toxin type A approximately 1–2 weeks before resurfacing.
Confirm the response and proceed with the planned ablative laser treatment.
Follow the laser device’s wound-care and recovery protocol.
Reassess results as healing and remodeling progress.

The exact timing may need adjustment based on the laser modality, treatment intensity, skin condition, medical history, and recovery response.

Match treatment intensity to the clinical goal

Ablative resurfacing can range from more superficial to more intensive treatment. Device selection, energy, density, depth, and treatment passes should be determined by a qualified clinician rather than by the presence of dynamic lines alone.

The appropriate plan balances the desired correction against healing time, pigmentary risk, and other procedure-specific complications.

Understanding the Trade-offs

Muscle relaxation does not stop all aging

Botulinum toxin provides temporary reduction in muscle activity; it does not permanently remove the treated muscles’ function or prevent future skin aging.

As its effect wears off, expression-related movement and the tendency for lines to recur can gradually return.

More treatment is not always better

Over-treatment can create an unnatural appearance, asymmetry, or unwanted restriction of facial movement. The goal is controlled reduction of excessive folding, not necessarily complete elimination of expression.

Similarly, more aggressive laser treatment does not automatically produce a better outcome if the underlying dynamic cause remains active.

Recovery and risk must be considered

Ablative resurfacing involves a meaningful healing period and requires careful aftercare. Potential concerns may include prolonged redness, infection, delayed healing, pigmentary changes, and other laser-related complications.

Botulinum toxin also has procedure-specific risks, including temporary asymmetry or unwanted weakness. Treatment should be performed by appropriately qualified medical professionals using a patient-specific plan.

Expectations should remain realistic

The combined approach can improve dynamic lines and skin quality, but it may not erase every crease. Deep static lines, volume loss, laxity, and other signs of facial aging may require separate evaluation.

The best results come from treating the actual cause of each concern rather than assuming one device or injection can address every aging mechanism.

Making the Right Choice for Your Goal

The treatment plan should be built around whether the main concern is movement, skin quality, or both.

If your primary focus is dynamic forehead, glabellar, or crow’s-feet lines: Consider botulinum toxin type A approximately 1–2 weeks before resurfacing to reduce muscle-driven creasing during healing.
If your primary focus is texture, photodamage, or static etched-in lines: Use ablative resurfacing as the skin-directed treatment, while recognizing that it will not independently control facial muscle movement.
If your primary focus is a longer-lasting combined result: Coordinate both treatments under a qualified clinician so muscle relaxation overlaps with the early collagen synthesis and remodeling period.
If your primary focus is safety and natural expression: Favor individualized dosing and conservative treatment planning rather than maximum muscle immobilization or maximum laser intensity.

The most effective strategy is to resurface the skin while temporarily reducing the muscle movements that would otherwise recreate the lines.

Summary Table:

Treatment Component	Primary Target	Mechanism	Timing	Contribution
Ablative Laser Resurfacing	Skin surface and static lines	Removes damaged skin layers; stimulates collagen remodeling	At the procedure	Improves texture, photodamage, and etched-in lines; does not stop muscle contractions
Botulinum Toxin Type A	Underlying facial muscles	Temporarily reduces muscle contractions that cause dynamic lines	1-2 weeks before laser	Prevents muscle-driven creasing during healing; complements laser effects
Combined Approach	Both skin and muscle	Addresses both surface damage and dynamic folding	Sequential	Provides more complete and durable improvement of expression lines

Ready to enhance your patients' outcomes with advanced combination therapies? At BELIS, we specialize in professional-grade medical aesthetic equipment for clinics and premium salons. Our portfolio includes ablative laser systems (CO2 Fractional, Erbium) and complementary devices such as botulinum toxin adjuvants, IPL, and more. Partner with us to elevate your practice with cutting-edge technology and expert support. Contact us today to discover how BELIS can help you achieve superior results and grow your business.